Pfizer to sell Paxlovid in China as COVID cases surge
Pfizer Inc. cemented a deal first announced in March to sell its antiviral medication Paxlovid in China through a state-owned company, adding to supply of COVID treatments in the country that’s now facing a massive infection surge.
Tribune News Service ·